Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma.

Chang SL, Lee SW, Yang SF, Chien CC, Chan TC, Chen TJ, Yang CC, Li CF, Wei YC

Open source

DOI
10.1111/apm.13023
Published
2020 Apr
Container
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/apm.13023,
  title = {Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma.},
  author = {Chang SL and Lee SW and Yang SF and Chien CC and Chan TC and Chen TJ and Yang CC and Li CF and Wei YC},
  year = {2020},
  journal = {APMIS : acta pathologica, microbiologica, et immunologica Scandinavica},
  doi = {10.1111/apm.13023},
  url = {https://doi.org/10.1111/apm.13023}
}

RIS

TY  - JOUR
TI  - Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma.
AU  - Chang SL
AU  - Lee SW
AU  - Yang SF
AU  - Chien CC
AU  - Chan TC
AU  - Chen TJ
AU  - Yang CC
AU  - Li CF
AU  - Wei YC
PY  - 2020
JO  - APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
DO  - 10.1111/apm.13023
UR  - https://doi.org/10.1111/apm.13023
ER  - 

APA

SL, C., SW, L., SF, Y., CC, C., TC, C., TJ, C., CC, Y., CF, L., & YC, W. (2020). Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma.. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. https://doi.org/10.1111/apm.13023

Source records